13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001214659-23-002379
Total Value
$642.2M
Positions
32
Other Managers
0
Confidential Omitted
No
Holdings (32)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 3,160,000 | $163.4M | 25.44% |
| 2 | CHINOOK THERAPEUTICS INC | 16961L106 | 2,551,703 | $66.9M | 10.41% |
| 3 | VERONA PHARMA PLC | 925050106 | 2,468,000 | $64.5M | 10.04% |
| 4 | ARCUS BIOSCIENCES INC | RCUS | 2,482,700 | $51.3M | 7.99% |
| 5 | MIRATI THERAPEUTICS INC | 60468T105 | 750,000 | $34.0M | 5.29% |
| 6 | CELLDEX THERAPEUTICS INC NEW | CLDX | 761,398 | $33.9M | 5.28% |
| 7 | IVERIC BIO INC | 46583P102 | 1,278,000 | $27.4M | 4.26% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 824,200 | $24.1M | 3.75% |
| 9 | TANDEM DIABETES CARE INC | TNDM | 474,929 | $21.3M | 3.32% |
| 10 | AEROVATE THERAPEUTICS INC | 008064107 | 621,712 | $18.2M | 2.84% |
| 11 | SPDR SER TR | 78464A870 | 199,417 | $16.6M | 2.58% |
| 12 | VERA THERAPEUTICS INC | VERA | 665,156 | $12.9M | 2.00% |
| 13 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 220,953 | $11.7M | 1.82% |
| 14 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,859,200 | $11.7M | 1.82% |
| 15 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 499,996 | $11.1M | 1.73% |
| 16 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,225,000 | $9.0M | 1.40% |
| 17 | ITEOS THERAPEUTICS INC | 46565G104 | 445,000 | $8.7M | 1.35% |
| 18 | VIKING THERAPEUTICS INC | VKTX | 870,500 | $8.2M | 1.27% |
| 19 | AVIDITY BIOSCIENCES INC | 05370A108 | 324,629 | $7.2M | 1.12% |
| 20 | BRIDGEBIO PHARMA INC | BBIO | 933,743 | $7.1M | 1.11% |
| 21 | STOKE THERAPEUTICS INC | STOK | 763,456 | $7.0M | 1.10% |
| 22 | XILIO THERAPEUTICS INC | XLO | 2,425,000 | $6.5M | 1.02% |
| 23 | 89BIO INC | 282559103 | 380,000 | $4.8M | 0.75% |
| 24 | GOSSAMER BIO INC | GOSS | 1,958,069 | $4.2M | 0.66% |
| 25 | MIRUM PHARMACEUTICALS INC | MIRM | 100,000 | $1.9M | 0.30% |
| 26 | PRAXIS PRECISION MEDICINES I | PRAX | 800,000 | $1.9M | 0.30% |
| 27 | DEXCOM INC | DXCM | 15,000 | $1.7M | 0.26% |
| 28 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 15,000 | $1.6M | 0.26% |
| 29 | JOUNCE THERAPEUTICS INC | 481116101 | 1,400,000 | $1.6M | 0.24% |
| 30 | MEREO BIOPHARMA GROUP PLC | MREO | 1,000,000 | $750,000 | 0.12% |
| 31 | NUVALENT INC | NUVL | 25,000 | $744,500 | 0.12% |
| 32 | CENTURY THERAPEUTICS INC | IPSC | 45,000 | $230,850 | 0.04% |